Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Glargine in Pediatric DKA
NCT03107208Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Jul 2017
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine in diabetic ketoacidosis (DKA) (2 arms), sponsored by University of Colorado Denver. Primary endpoint: Rate of Rebound Hyperglycemia. Started Jul 2017; status: completed.
02
Drugs
insulin glargine
03
Conditions
diabetic ketoacidosis (DKA)
Beyond the preview
Go deeper on NCT03107208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03107208.